Ticker	Current Price	Change	Graph
IBB	112.81	0.77 (0.69%)
XBI	100.28	1.43 (1.45%)

Drug Development

GSK vs Gilead: Heavyweight HIV fight will come down to a big showdown in Amsterdam next month

People

Buffett, Dimon and Bezos find their miracle man, charged with fixing a broken healthcare system

Collaborations, Deals

Novo takes on gut-brain axis discovery with Kallyope, focusing on obesity and diabetes

Latest

NEWBiopharma rivals at Roche and Bayer both stand to benefit from the trend toward increased testing of cancer patients →

With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai's Alpha Bio zooms into a PhII study →

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub →

Anika Therapeutics shares crater as its 2nd PhIII OA study flops -- drug combo pales in comparison to a steroid →

Vertex expands its San Diego R&D hub, adding a new wing for collaborators as it centers on CF research →

Building up its rare obesity pipeline, Rhythm Pharma to raise $150M →

Sarepta leads off Duchenne MD gene therapy study with a ‘home run’ on efficacy — but can they deliver in 2 years? →

Mega-money biotech round spills $116M into gene therapy upstart Freeline →

Determined to build the leading biotech player in a new R&D space, Steven Holtzman lines up $55M for the next stage at Decibel →

Top News

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

Amber Tong

Valeant nosedives on CRL for plaque psoriasis, raising concerns over touted $1B pipeline

Brittany Meiling

Spinraza rival? With DMD flops in the rearview mirror, PTC Therapeutics posts strong SMA data

Brittany Meiling

Johns Hopkins spinout WindMIL grabs $32.5M to fuel its work on a next-gen approach to cell therapy

Amber Tong

From top analyst to CFO: Cowen’s Eric Schmidt leaps into the top ranks of biotech’s latest overnight sensation

John Carroll

More news

Protocols

Quick hits from around the biopharma web

Jun 20

Celgene/Receptos exec jumps to Kura as new COO; TG Therapeutics allies with Novimmune on $185M bispecific deal

Jun 19

Alexion shoots for fast review of Soliris successor using a PRV; Sandoz wades into medical cannabis business

Jun 18

Seven biotech IPOs ready to roll; Celltrion's Herceptin biosim gets second review at FDA

Jun 14

Sanofi sells manufacturing site to Recipharm; Aptose buys rights to sell CrystalGenomics' cancer drug in China

More Protocols

Premium

The 2-trial hurdle for drug approvals is steadily losing ground. Are we devaluing the industry's R&D gold standard?

Where does the science come from? The top 20 NIH-funded institutions in 2017

The good, the bad and the ugly for the top 15 spenders in the global drug R&D business: 2018

Bristol-Myers offers some eagerly awaited Checkmate-227 results, but they're not changing medical practice -- yet

What are the top 10 corporate VCs in biopharma today? And what do they want to fund — or steer clear of?

Where the money is: Top 100 VCs investing in US biotechs during 2017

Marco

Hot BioTwitter bot - last updated ago

Most Viral

Finding Cancer Patients Is Pharma Industry's Unlikely Challenge

Bloomberg Naomi Kresge a day

Atul Gawande picked as CEO of Amazon, Berkshire health care company

STAT a day

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub

ENDPOINTS NEWS John Carroll a day

Purdue Pharma, company behind Oxycontin, just laid off its entire sales team

VICE News a day

Amazon, Berkshire Hathaway and JPMorgan Chase appoint Dr. Atul Gawande as Chief Executive Officer of their newly-formed company to address U.S. employee healthcare

BusinessWire a day

Mediterranean Diet Study 'Seriously Flawed': Ioannidis

MedScape a day

Oncology play iTeos raises $75M, outlines clinical plans

BioCentury a day

Small Molecules and Gene Therapy Muscle Out Oligonucleotide Therapeutics

Rnaitherapeutics Dirk Haussecker a day

Buffett, Bezos, Dimon appoint Dr. Atul Gawande as CEO of their newly formed health care company

CNBC Angelica LaVito a day

There Go Those Drug Companies Inventing New Diseases Again

Forbes a day

Latest

STAT

Atul Gawande picked as CEO of Amazon, Berkshire health care company

CNBC

Buffett, Bezos, Dimon appoint Dr. Atul Gawande as CEO of their newly formed health care company

BusinessWire

Amazon, Berkshire Hathaway and JPMorgan Chase appoint Dr. Atul Gawande as Chief Executive Officer of their newly-formed company to address U.S. employee healthcare

Rnaitherapeutics

Small Molecules and Gene Therapy Muscle Out Oligonucleotide Therapeutics

Reuters

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

VICE News

Purdue Pharma, company behind Oxycontin, just laid off its entire sales team

Reuters

Ebola outbreak in Congo 'largely contained', says WHO

The Globe and Mail

Opioid-related deaths soar in British Columbia, Alberta

Reuters

Latecomer Sanofi looks to catch next wave of cancer therapies

Bloomberg

Finding Cancer Patients Is Pharma Industry's Unlikely Challenge

Hot This Week

1

WSJ

U.S. Files Criminal Charges Against Theranos's Elizabeth Holmes, Ramesh Balwani

2

Roche

Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology

3

STAT

New Bluebird data show promising benefits for gene therapy, if they last

4

Bloomberg

Google Is Training Machines to Predict When a Patient Will Die

5

Nature

New human gene tally reignites debate

6

STAT

Controversial NIH study of 'moderate drinking' will be terminated

7

STAT

Sarepta's gene therapy for Duchenne raises hopes for 'real change'

8

GlobeNewswire News Room

Solid Biosciences Announces FDA Removes Clinical Hold on SGT-001

9

CNBC

Theranos founder Elizabeth Holmes out as CEO, three months after 'massive fraud' claims

10

Bloomberg

GSK vs Gilead: Heavyweight HIV fight will come down to a big showdown in Amsterdam next month

Buffett, Dimon and Bezos find their miracle man, charged with fixing a broken healthcare system

Novo takes on gut-brain axis discovery with Kallyope, focusing on obesity and diabetes

Latest

NEWBiopharma rivals at Roche and Bayer both stand to benefit from the trend toward increased testing of cancer patients →

With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai's Alpha Bio zooms into a PhII study →

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub →

Anika Therapeutics shares crater as its 2nd PhIII OA study flops -- drug combo pales in comparison to a steroid →

Vertex expands its San Diego R&D hub, adding a new wing for collaborators as it centers on CF research →

Building up its rare obesity pipeline, Rhythm Pharma to raise $150M →

Sarepta leads off Duchenne MD gene therapy study with a ‘home run’ on efficacy — but can they deliver in 2 years? →

Mega-money biotech round spills $116M into gene therapy upstart Freeline →

Determined to build the leading biotech player in a new R&D space, Steven Holtzman lines up $55M for the next stage at Decibel →

Top News

Protocols

Premium

The 2-trial hurdle for drug approvals is steadily losing ground. Are we devaluing the industry's R&D gold standard?

Where does the science come from? The top 20 NIH-funded institutions in 2017

The good, the bad and the ugly for the top 15 spenders in the global drug R&D business: 2018

Bristol-Myers offers some eagerly awaited Checkmate-227 results, but they're not changing medical practice -- yet

What are the top 10 corporate VCs in biopharma today? And what do they want to fund — or steer clear of?

Where the money is: Top 100 VCs investing in US biotechs during 2017

Most Viral

Latest

Hot This Week

Contact Endpoints News

Sign in to Endpoints News

Request a magic link

Set a new password